Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing
Steyaert, W.; Sagath, L.; Demidov, G.; Yepez, V. A.; Esteve-Codina, A.; Gagneur, J.; Ellwanger, K.; Derks, R.; Weiss, M.; den Ouden, A.; van den Heuvel, S.; Swinkels, H.; Zomer, N.; Steehouwer, M.; O'Gorman, L.; Astuti, G.; Neveling, K.; Schule, R.; Xu, J.; Synofzik, M.; Beijer, D.; Hengel, H.; Schoels, L.; Claeys, K. G.; Baets, J.; Van de Vondel, L.; Ferlini, A.; Selvatici, R.; Morsy, H.; Saeed Abd Elmaksoud, M.; Straub, V.; Muller, J.; Pini, V.; Perry, L.; Sarkozy, A.; Zaharieva, I.; Muntoni, F.; Bugiardini, E.; Polavarapu, K.; Horvath, R.; Reid, E.; Lochmuller, H.; Spinazzi, M.; Savarese, M
Show abstract
Solve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilised 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single nucleotide variants (SNVs), insertion-deletions (InDels), and short tandem repeat (STR) expansions in extensively studied RD families without clear molecular diagnoses. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Rare Disease Network (ERN) experts. Of these, 21 families were affected by so-called unsolvable syndromes for which genetic causes remain unknown, and 93 families with at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without genetic diagnosis despite extensive prior testing. Clinical interpretation and orthogonal validation of variants in known disease genes yielded thirteen novel genetic diagnoses due to de novo and rare inherited SNVs, InDels, SVs, and STR expansions. In an additional four families, we identified a candidate disease-causing SV affecting several genes including an MCF2/FGF13 fusion and PSMA3 deletion. However, no common genetic cause was identified in any of the unsolvable syndromes. Taken together, we found (likely) disease-causing genetic variants in 13.0% of previously unsolved families and additional candidate disease-causing SVs in another 4.3% of these families. In conclusion, our results demonstrate the added value of HiFi long-read genome sequencing in undiagnosed rare diseases.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection 96%
- Non-coding variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms 94%
- HiFi long-read genomes for difficult-to-detect clinically relevant variants 94%
Similar papers in this journal
- A common flanking variant is associated with enhanced meiotic stability of the FGF14-SCA27B locus 95%
- Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption 95%
- Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder 93%
Similar papers in this journal
- Multi-modal investigation of the schizophrenia-associated 3q29 genomic interval reveals global genetic diversity with unique haplotypes and segments that increase the risk for non-allelic homologous recombination 94%
- Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance 94%
- Systematic analysis of genetic and phenotypic characteristics reveals antisense oligonucleotide therapy potential for one-third of neurodevelopmental disorders 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.